Assessing the Gold Standard — Lessons from the History of RCTs
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Randomized, controlled trials have become the gold standard of medical knowledge. Yet their scientific and political history offers lessons about the complexity of medicine and disease and the economic and political forces shaping the production and circulation of knowledge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized clinical trials (RCT) serve as the most valid study design to inform clinical practice according to evidence-based medicine (EBM) principles.1,2”
From Integrity of randomized clinical trials: Performance of integrity tests and checklists requires assessment (2023) · cites this paper as [1]
Citations
Cites
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Zika Virus Infection in Pregnant Women in Rio de Janeiro
Brasil, P., Pereira, J. P., Moreira, M. E., Ribeiro Nogueira, R. M., Damasceno, L., Wakimoto, M., Rabello, R. S., Valderramos, S. G., Halai, U.-A., Salles, T. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602412 · Cited by 2,196
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
Moseley, J. B., O'Malley, K., Petersen, N. J., Menke, T. J., Brody, B. A., Kuykendall, D. H., Hollingsworth, J. C., Ashton, C. M., & Wray, N. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013259 · Cited by 2,149
Impure Science: AIDS, Activism, and the Politics of Knowledge
(1997) · Nature Medicine · doi:10.1038/nm0297-242 · Cited by 1,666
The effectiveness of psychotherapy: the Consumer Reports study
Seligman, M. E. P. (1995) · American Psychologist · doi:10.1037/0003-066x.50.12.965 · Cited by 1,608
Emergence of Zaire Ebola Virus Disease in Guinea
Baize, S., Pannetier, D., Oestereich, L., Rieger, T., Koivogui, L., Magassouba, N., Soropogui, B., Sow, M. S., Keïta, S., De Clerck, H., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404505 · Cited by 1,366
TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSIS
Grüntzig, A. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90500-7 · Cited by 1,343
Instruments, Randomization, and Learning about Development
Deaton, A. (2010) · Journal of Economic Literature · doi:10.1257/jel.48.2.424 · Cited by 1,286
A review of uses of health care utilization databases for epidemiologic research on therapeutics
Schneeweiss, S., & Avorn, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.012 · Cited by 1,277
Research works printed but not linked: 3
- Podolsky SH, Jones DS, Kaptchuk TJ. From trials to trials: blinding, medicine, and honest adjudication. In: Robertson CT, Kesselheim AS, eds. Blinding as a solution to bias: strengthening biomedical science, forensic science, and law. Amsterdam: Elsevier, 2016:45-58.
- Kuo W-H. Japan and Taiwan in the wake of bio-globalization: drugs, race and standards (Ph.D. dissertation). Cambridge: Massachusetts Institute of Technology, 2005.
- Rothman DJ, 2000, New York Rev Books, 47, 60
Cited by
Items 201–300 of 698
Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals
Evans, M., Lewis, E. D., Antony, J. M., Crowley, D. C., Guthrie, N., & Blumberg, J. B. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.958753 · Cited by 16
“stated “even though RCTs were developed to produce generalizable and universal knowledge, they have remained entangled in local social, economic and political conditions” (20).”
BackgroundSalcher‐Konrad, M., Nguyen, M., Savović, J., Higgins, J. P. T., & Naci, H. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.36230 · Cited by 22
Chen, D. C., Arnold, K., Sukhdeo, R., Alla, J. F., & Raman, S. (2025) · BMJ Oncology · doi:10.1136/bmjonc-2025-000733 · Cited by 16
“8 Due to its importance in evidence-based medicine, the integrity of an RCT’s findings depends heavily on the quality of its design, conduct and reporting.”
Bartoli, F., Clerici, M., Brita, C. D., Riboldi, I., Crocamo, C., & Carrà, G. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117749851 · Cited by 16
Fragility of randomized clinical trials of treatment of clavicular fractures
Ruzbarsky, J. J., Khormaee, S., Rauck, R. C., & Warren, R. F. (2019) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2018.11.039 · Cited by 16
Gabriel, L., Young, J., Hoesli, I. M., Girard, T., & Dell‐Kuster, S. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.02.016 · Cited by 16
Sánchez‐Viñas, A., Corral‐Partearroyo, C., Gil‐Girbau, M., Peñarrubia‐María, M. T., Gallardo‐Gonzalez, C., Olmos-Palenzuela, M. D. C., Aznar‐Lou, I., Serrano‐Blanco, A., & Rubio-Valera, M. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01727-6 · Cited by 17
Antenatal corticosteroids for the late preterm infant and agnotology
Kaempf, J. W., & Suresh, G. (2017) · Journal of Perinatology · doi:10.1038/jp.2017.76 · Cited by 16
Chau, I., Le, D. T., Ott, P. A., Korytowsky, B., Le, H., Le, T. K., Zhang, Y., Sánchez, T., Maglinte, G. A., Laurie, M., et al. (2019) · Gastric Cancer · doi:10.1007/s10120-019-01008-9 · Cited by 16
Abramowitz, L., Brochard, C., Pigot, F., Roumeguere, P., Pillant, H., Bonnet, B. V., Faucheron, J., Sénéjoux, A., Bonnaud, G., Meurette, G., et al. (2021) · Colorectal Disease · doi:10.1111/codi.15947 · Cited by 15
“The randomized design of study was in fact originally set up to compare medical versus placebo therapy [32].”
BackgroundA comprehensive survey of the clinical trial Landscape on digital therapeutics
Yao, H., Liao, Z., Zhang, X., Zhang, X., Li, M., You, L., & Liu, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36115 · Cited by 16
Kanenawa, K., Yamaji, K., Tashiro, H., Domei, T., Andò, K., Watanabe, H., & Kimura, T. (2021) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.010007 · Cited by 15
“The exclusion criteria were (1) patients who had in-hospital major complications other than periprocedural myocardial infarction (MI) such as death, nonperiprocedural MI, stroke, or major bleeding; (2) patients who needed anticoagulants or antiplatelet therapy other than aspirin and P2Y12 receptor blockers; (3) patien…”
BackgroundThiessen, M. H., Harris, D., Pinches, A., Vaska, M. M., Moules, N. J., Bouchal, S. R., & Sinclair, S. (2022) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2022.104174 · Cited by 15
van Oostveen, R. B., Romero-Palacios, A., Whitlock, R. P., Lee, S. F., Connolly, S. J., Carignan, A., Mazer, C. D., Loeb, M. B., & Mertz, D. (2018) · Trials · doi:10.1186/s13063-018-3080-y · Cited by 15
NCoRE: Neural Counterfactual Representation Learning for Combinations of TreatmentsPreprint
Parbhoo, S., Bauer, S., & Schwab, P. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2103.11175 · Cited by 16
“However, in many settings of interest, randomised experiments are too expensive or time-consuming to execute, or not possible for ethical reasons (Carpenter, 2014; Bothwell et al., 2016).”
BackgroundBorges, F. C., van der Graaf, W. T. A., Saesen, R., Aebi, S. P., Amariutei, A. E., Bekelman, J. E., Gorlia, T., Hulstaert, F., Huys, I., Kluetz, P. G., et al. (2025) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00756-3 · Cited by 14
Bödeker, W., & Moebus, S. (2019) · Das Gesundheitswesen · doi:10.1055/a-0832-2220 · Cited by 14
Panteleimonitis, S., Pickering, O. J., Ahmad, M., Harper, M., Qureshi, T., Figueiredo, N., & Parvaiz, A. C. (2019) · Laparoscopic Endoscopic and Robotic Surgery · doi:10.1016/j.lers.2019.12.002 · Cited by 14
Liao, L., Zhuang, X., Zhang, S., Liao, X.-X., & Li, W. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.09.068 · Cited by 16
Blasdel, G., Dy, G. W., Nikolavsky, D., Ferrando, C. A., Bluebond‐Langner, R., & Zhao, L. C. (2023) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000010813 · Cited by 16
“65 Acknowledging the need for exploration and surgical skill building before randomized trials, the IDEAL (idea, development, exploration, assessment, long-term study) framework describes best practice in surgical technique innovation.”
BackgroundCao, S., Wei, Y., Yue, Y., Li, G., Wang, H., Lin, J., Wang, Q., Liu, P., Yu, F., Xiong, A., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05255-y · Cited by 14
“At the pinnacle of the evidence hierarchy for studying therapeutic impacts on diseases stands the randomized controlled trial (RCT) [22].”
BackgroundManualizing psychotherapy: Aaron T. Beck and the origins of Cognitive Therapy of Depression
Rosner, R. I. (2018) · European Journal of Psychotherapy & Counselling · doi:10.1080/13642537.2017.1421984 · Cited by 20
“Congress and NIH administrators were demanding accountability and the RCT became the method of choice – even as skepticism about RCTs within the medical community remained (Bothwell et al., 2016; Jones, 2000).”
MethodRezende, L. F. M., Rey-López, J. P., de Sá, T. H., Chartres, N., Fabbri, A., Powell, L., Stamatakis, E., & Bero, L. A. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005761 · Cited by 15
Nonpharmacological Treatment for Supporting Social Participation of Adults with Depression
Phadsri, S., Shioji, R., Tanimura, A., Jaknissai, J., Apichai, S., & Sookruay, T. (2021) · Occupational Therapy International · doi:10.1155/2021/8850364 · Cited by 15
“Although randomized control trial (RCT) studies have been accepted as the gold standard of study design to examine the effects of an intervention [23], this study considered setting an eligibility criteria for participants that might influence the response of an intervention program; for example, age, diagnosis, and s…”
Backgroundvan Oostendorp, J. Y., Dekker, L., van Dieren, S., Veldkamp, R., Bemelman, W. A., Han‐Geurts, I. J. M., & On behalf of the HollAND Study Group (2025) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000003679 · Cited by 13
“Statistical analyses were performed using SPSS Statistics 28 (IBM, Armonk, NY).”
A Radical Approach to Ebola: Saving Humans and Other Animals
Edwards, S., Norell, C. H., Illari, P. K., Clarke, B., & Neuhaus, C. P. (2018) · The American Journal of Bioethics · doi:10.1080/15265161.2018.1513584 · Cited by 14
“Unreflective reliance on clinical effects observed from large RCTs is beginning to wane (Bothwell et al. 2016).”
BackgroundSawers, N., Bolster, N. M., & Bastawrous, A. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.752049 · Cited by 18
“The randomized control trial (RCT) has been the gold standard in medicine since the late twenty-first century (39).”
Pape, L., DeZwaan, M., Nöhre, M., Klewitz, F., Tun, E. K. T., Prüfe, J., Schiffer, L. E., Gertges, R., Schieffer, E., Albrecht, A. A., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102652 · Cited by 13
“Due to speci fi cations of the funding agency, a randomized controlled design, which is considered the gold standard for therapeutic clinical trials, 26 could not be used and a cluster-randomized design was not feasible due to the low number of participating centres in our study.”
Evolution of Clinical Trials throughout History
Nellhaus, E. M., & Davies, T. H. (2017) · Marshall Journal of Medicine · doi:10.18590/mjm.2017.vol3.iss1.9 · Cited by 13
“History has proven that standardized clinical trials answer questions other approaches of scientific investigation cannot.(21) Modern challenges, including big data, pharmaceutical and device companies designing trials for marketing, monetary considerations, time constraints, and expanding public health data present n…”
BackgroundHernández, J. M. D. L. T., & Edelman, E. R. (2017) · Revista Española de Cardiología · doi:10.1016/j.recesp.2017.07.017 · Cited by 13
How to improve intervention research on the psychosocial work environment?
Alex Burdorf, A. (2023) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.4107 · Cited by 13
“Although in recent years the RCT has given way to more flexible approaches, the strong reliance on this type of decisive study design in evidence production has had unintended consequences (1).”
BackgroundTao, Y., Li, X., Yisha, Z., Yang, S., Zhan, S., & Sun, F. (2025) · Health Data Science · doi:10.34133/hds.0322 · Cited by 13
“Pre-market randomized controlled trials are invaluable, providing initial assessments of drug efficacy and safety under controlled conditions, which are essential for drug approval and integral to the drug development process [ 7 , 8 ].”
Simaeys, H. V., Mannaerts, L., Serraes, B., & Clays, E. (2025) · BMC Public Health · doi:10.1186/s12889-025-23540-3 · Cited by 12
“While randomized controlled trials (RCTs) are considered the gold standard for establishing causality, they are often impractical in acute care settings due to ethical, logistical, and organizational barriers [32].”
A REDCap advanced randomization module to meet the needs of modern trials
Stevens, L., Kennedy, N., Taylor, R. J., Lewis, A., Harrell, F. E., Shotwell, M. S., Serdoz, E. S., Bernard, G. R., Self, W. H., Lindsell, C. J., et al. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2025.104925 · Cited by 12
Integrative oncology from a bibliometric point of view
Danell, J.-A. B. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102477 · Cited by 13
An investigation into the factors affecting investigator-initiated trial start-up in Ireland
Leddy, L., Sukumar, P., O’Sullivan, L., Keane, F., Devane, D., & Doran, P. (2020) · Trials · doi:10.1186/s13063-020-04893-z · Cited by 13
Jandhyala, R. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1947218 · Cited by 14
Sheldon, R. E. (2017) · NeoReviews · doi:10.1542/neo.18-10-e568 · Cited by 12
Cooper, A. C. G. (2018) · Energy Efficiency · doi:10.1007/s12053-018-9618-8 · Cited by 12
“However, even in the medical research, the use of RCTs is far from either uncontested or seen as a ‘gold standard’, as Bothwell et al. (2016) elegantly demonstrate.”
BackgroundRiley, A. R., & Freeman, K. A. (2019) · Behavior Analysis Research and Practice · doi:10.1037/bar0000114 · Cited by 12
Analysis of Factors Influencing the Efficiency of Acupuncture in Tinnitus Patients
Lin, T.-Y., Yang, S., Lee, Y., Wu, P., Young, C., Li, T.-H., & Chou, W.-L. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/1318639 · Cited by 12
“The old methods, such as large databases, case series, and even case reports, still play an essential role in medical knowledge production [38].”
MethodInnovative Care in Latin America: Definition, Justification and Ethical Principles
Holzer, F., & Mastroleo, I. (2019) · International library of ethics, law, and the new medicine/The international library of ethics, law, and the new medicine · doi:10.1007/978-3-030-17963-2_9 · Cited by 12
Epilogue: Randomization and Social Policy Evaluation Revisited
Heckman, J. J. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780198865360.003.0014 · Cited by 13
The “pragmatic trial”: An essentially contested concept?
Pawson, R. (2019) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13216 · Cited by 13
Dorsal root ganglion stimulation device explantation: A multicenter pooled data analysis
Chapman, K. B., Yang, A. H., Mogilner, A. Y., Mandelberg, N. J., Patel, K. V., Lubenow, T. R., Deer, T. R., Kallewaard, J. W., & van Helmond, N. (2022) · Pain Practice · doi:10.1111/papr.13113 · Cited by 12
“clinical trial designs.(2) The fundamental similarity between spinal cord stimulation (SCS) and DRG- S – placing a flexible electrode, energized by an implantable pulse generator (IPG), over a neuronal target accessed via the epidural space – invites a comparison of the two modalities.”
BackgroundThe captive brain: torture and the neuroscience of humane interrogation
O’Mara, S. M. (2018) · QJM · doi:10.1093/qjmed/hcx252 · Cited by 13
Buccheri, S., James, S. K., Mafham, M., Landray, M., Melvin, T., Oldgren, J., Bulbulia, R. A., Bowman, L. J., Hoogervorst, L. A., de Mheen, P. J. M., et al. (2025) · Trials · doi:10.1186/s13063-025-08724-x · Cited by 13
“Randomized clinical trials (RCTs) provide the foundation of evidence-based medicine [1].”
Dalgaard, V. L., Kirkegaard, T., Wåhlin-Jacobsen, C. D., Aust, B., Jaspers, S. Ø., Jønsson, T., & Winding, T. N. (2025) · BMC Public Health · doi:10.1186/s12889-024-20801-5 · Cited by 12
Human-AI Complementarity in Diagnostic Radiology: The Case of Double Reading
Wagner, I. A., & Chakradeo, K. (2025) · Philosophy & Technology · doi:10.1007/s13347-025-00886-5 · Cited by 11
“…the cost of reduced specificity in diagnostics generally (Fawcett, 2006), some of the above studies suggest that this trade-off can 20 Among the studies discussed, RCTs are widely regarded as providing the highest quality evidence due to their ability to isolate variables (Bothwell et al., 2016).”
Wu, Y., Huang, J.-R., Guo, J., Lian, W., & Suo, M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1631727 · Cited by 16
Show drugs work before selling them
Sipp, D., McCabe, C. J., & Rasko, J. E. J. (2017) · Nature · doi:10.1038/543174a · Cited by 11
Assessing the Value of the ARRIVE Trial for Clinical Practice: Sea Change or Just a Splash?
Phillippi, J. C., & King, T. L. (2018) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12928 · Cited by 11
Fu, R., Hou, J., Gu, Y., & Yu, N. X. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03768-5 · Cited by 11
“Another important point is that, with RCTs as the gold standard of evidence for intervention studies in the twenty-first century [15], using RCTs to evaluate the intervention effects of improving the health and well-being of key populations in the face of widespread global health inequities is now one of many pressing…”
BackgroundSilva, P. J., Janjan, N. A., Ramos, K. S., Udeani, G., Zhong, L., Ory, M. G., & Smith, M. L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1198088 · Cited by 11
“Two key conclusions were determined from this study: (1) real world endpoints are valid and should be used to support regulatory and payer decisionmaking; and (2) observed differences likely reflected true differences between real world and clinical trial populations and practices.”
BackgroundMethodSpriensma, A. S., Eekhout, I. E., de Boer, M. R., Luime, J. J., de Jong, P. H., Bahçecitapar, M. K., Heymans, M. W., & Twisk, J. W. R. (2022) · Epidemiology Biostatistics and Public Health · doi:10.2427/12850 · Cited by 13
“Randomized controlled trials (RCTs) are assumed to be the gold standard to estimate treatment effects [1].”
Brokowski, C., & Adli, M. (2020) · The CRISPR Journal · doi:10.1089/crispr.2019.0051 · Cited by 11
“3.”
ICU management based on big data
Falini, S., Angelotti, G., & Cecconi, M. (2020) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000834 · Cited by 12
“movement of evidence-based medicine [15].”
Rethinking the Endpoints of mHealth Intervention Research in Diabetes Care
Modzelewski, K. L., Stockman, M.-C., & Steenkamp, D. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817733007 · Cited by 11
Probst, H., & Ramlaul, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-37944-5_12 · Cited by 11
Street-Level Theories of Change: Adapting the Medical Model of Evidence-Based Practice for PolicingPreprint
Cowen, N., & Cartwright, N. D. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3324778 · Cited by 12
Luo, Y., Zhao, X., Wang, R., Zhan, X., Zhang, T., He, T., Jing, J., Li, J., Li, F., Zhang, P., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.12.024 · Cited by 10
Gil, A. G., de Palencia, Á. C. F., Gómez, A. G., Gil‐Gómez, E., Hernández, F. L., Díaz, A. N., Martínez, J., Marhuenda, I., & Cascales-Campos, P. A. (2023) · Cancers · doi:10.3390/cancers15133481 · Cited by 10
“Also particularly relevant is the fact that the vast majority of RCTs are not supported by the pharmaceutical industry [27].”
BackgroundAdaptive design trials in eating disorder research: A scoping review
Edney, L. C., & Pellizzer, M. L. (2024) · International Journal of Eating Disorders · doi:10.1002/eat.24198 · Cited by 11
Rastogi, S. (2017) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587217712764 · Cited by 10
“This case argues that Ayurvedic conventional therapies on the basis of their patient-centered responses require a serious consideration even if they do not comply with the benchmarks and gold standards of biomedical clinical researches.(9)”
BackgroundWade, T. D., Johnson, C., & Byrne, S. M. (2018) · International Journal of Eating Disorders · doi:10.1002/eat.22872 · Cited by 10
Greason, K. L., Blackstone, E. H., Rajeswaran, J., Lowry, A. M., Svensson, L. G., Webb, J. G., Tuzcu, E. M., Smith, C. R., Makkar, R., Mack, M. J., et al. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.04.112 · Cited by 10
Low Reporting of Cointerventions in Recent Cardiovascular Clinical Trials: A Systematic Review
Moutzouri, E., Adam, L., Feller, M., Syrogiannouli, L., da Costa, B. R., Giovane, C. D., Bauer, D. C., Aujesky, D., Chioléro, A., & Rodondi, N. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014890 · Cited by 10
“We also defined 2 special categories of cointerventions in (1) RCTs where there was an index procedure after randomization, in which case, in addition to concomitant medications (statins, antihypertensives, antiplatelets) over followup, procedural characteristics and periprocedural medications between the groups would…”
MethodMicrofinance RCTs in Development: Miracle or Mirage?
Bédécarrats, F., Guérin, I., & Roubaud, F. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780198865360.003.0009 · Cited by 34
Coquet, J., Bievre, N., Billaut, V., Seneviratne, M. G., Magnani, C. J., Bozkurt, S., Brooks, J. D., & Hernandez‐Boussard, T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.31730 · Cited by 11
Thomas, R., Cirera, L., Brew, J., Saúte, F., & Sicuri, E. (2021) · Health Economics · doi:10.1002/hec.4367 · Cited by 10
Trends in Adaptive Design Methods in Dialysis Clinical Trials: A Systematic Review
Judge, C. S., Murphy, R., Reddin, C., Cormican, S., Smyth, A., O’Halloran, M., & O'Donnell, M. J. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2021.08.001 · Cited by 12
“Randomized clinical trials (RCTs) are the gold standard for evaluating the efficacy, futility, or harm of new therapies.(2) Compared with similar medical specialties, nephrology has traditionally had a low number of RCTs,”
BackgroundIdentification and mapping of worldwide sources of generic real‐world data
Wang, X., Lahoz, R., Jawla, S., Przybysz, R., Kahler, K. H., Burdukova, L., Venkata, S. K., Nassim, M., Jalapu, A., & Justo, N. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4782 · Cited by 10
Naar, S., Hudgens, M. G., Brookmeyer, R., Carcone, A. I., Chapman, J. E., Chowdhury, S., Ciaranello, A. L., Comulada, W. S., Ghosh, S., Horvath, K. J., et al. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2019.0095 · Cited by 12
Taillandier, L., Obara, T., & Duffau, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719014 · Cited by 11
Asakawa-Haas, K. D., Spiegel, D., Bossert, L., Garić, A., Schwartz, K., Voracek, M., & Tran, U. S. (2026) · Communications Psychology · doi:10.1038/s44271-026-00414-x · Cited by 10
“Prior meta-analyses on the topic (see Table 1) followed the current gold standard in evidence-based research and analyzed RCTs only 39 , whereas the most recent attempt 40 applied even stricter criteria and focused exclusively on RCTs that used passive controls and an intention-to-treat (ITT)…”
Park, M. N., Kim, H. S., Park, S., Syahputra, R. A., Delfino, D. V., Ko, S., & Kim, B. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104111 · Cited by 9
“Adaptive enrichment strategies allow real-time modification of inclusion criteria based on interim biomarker analyses, enabling selective enrichment of patients exhibiting targetable redox vulnerabilities while discontinuing exposure in non-responsive subgroups [178].”
Shen, J., & Liu, Y. (2022) · Dermatologic Therapy · doi:10.1111/dth.15909 · Cited by 9
“Nevertheless, expensive costs and complicated preparation limit the use and quality of RCTs.(5) In a review of 141 RCTs, there has remained unsatisfactory in the recent dermatology literature for lack of similarity of interventions and prospective trial registration.”
BackgroundInfluentialDalgas, U., Riemenschneider, M., Gold, S. M., Kalron, A., Beckerman, H., de Groot, V., Dennett, R., Edwards, T. A., Pilutti, L. A., & Freeman, J. A. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585231204456 · Cited by 9
Kirat, H. E., Khattabi, A., Khalis, M., & Belrhiti, Z. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.10.021 · Cited by 9
Murphy, E. K., O’Keeffe, A., Shea, N. O., Long, E. B., Eustace, J. A., & Shiely, F. (2021) · Trials · doi:10.1186/s13063-021-05526-9 · Cited by 10
Kwon, J., Pelletiers, W., Galloway-Peña, J., van Duin, D., Ledbetter, L., Baum, K. R., Ruffin, F., Knisely, J. M., Bizzell, E., Fowler, V. G., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae049 · Cited by 9
Mahajan, M. (2017) · BioSocieties · doi:10.1057/s41292-017-0062-3 · Cited by 9
Schneider, J., & Jackson, S. (2018) · Argument & Computation · doi:10.3233/aac-180036 · Cited by 9
“RCT has some counterintuitive elements that required extensive defense by many advocates before it could be become the taken-for-granted “gold standard” for medical evidence [3].”
BackgroundBibliometric analysis of randomized controlled trials of colorectal cancer over the last decade
Wang, C.-Y., Zhou, S., Li, X., Li, B., Zhang, J., Ge, Z., Zhang, Q., & Hu, J. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i14.3021 · Cited by 9
Sivesind, T. E., Runion, T. M., Branda, M. E., Schilling, L. M., & Dellavalle, R. P. (2021) · Dermatology · doi:10.1159/000514536 · Cited by 9
Jaffe, K., Korthuis, P. T., & Richardson, L. (2021) · Qualitative Health Research · doi:10.1177/10497323211016408 · Cited by 9
“To evaluate the efficacy of medical treatments, randomized controlled trials (RCTs) are widely considered the “gold standard” study design (Bothwell et al., 2016).”
BackgroundMethodSaeed, M., Swaroop, M., Ackerman, D. J., Tarone, D. M., Rowbotham, J., & Stawicki, S. P. (2018) · InTech eBooks · doi:10.5772/intechopen.76778 · Cited by 10
“This may have important implications during study design, especially when establishing appropriate inclusion criteria or standardizing experimental interventions [3, 4, 18, 38].”
BackgroundYao, X., Zhang, X., Cui, T., Jian, M., Wu, H., Wu, C., & Tao, F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1573901 · Cited by 8
How to Conduct a Randomized Controlled Trial
Kaur, R., & Li, J. (2023) · Respiratory Care · doi:10.4187/respcare.11351 · Cited by 10
Butt, F., Núñez‐Núñez, M., Juhász, B., Bueno‐Cavanillas, A., & Khan, K. S. (2024) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2024.102333 · Cited by 8
Wirtz, M. A., & Schulz, A. A. (2020) · Die Rehabilitation · doi:10.1055/a-1064-6587 · Cited by 10
Li, Y., Yu, Q., Chen, N., Ge, L., Wang, Q., Aboudou, T., Han, J., Hou, L., Cao, L., Li, R., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1069879 · Cited by 9
“Despite some limitations, RCTs are the gold standard for evaluating the clinical efficacy of intervention strategies and an essential basis for developing SRs (Shamseer et al., 2015; Bothwell et al., 2016).”
BackgroundUse of external control arms in immune-mediated inflammatory diseases: a systematic review
Zayadi, A., Edge, R., Parker, C. E., MacDonald, J. K., Neustifter, B., Chang, J., Zhong, G., Singh, S., Feagan, B. G., Ma, C., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-076677 · Cited by 8
Reliable Data Collection in Participatory Trials to Assess Digital Healthcare Applications
Park, J., Park, S., Kim, G., Kim, K., Jung, J., Yoo, S., Yi, G., & Lee, D. (2020) · IEEE Access · doi:10.1109/access.2020.2985122 · Cited by 8
“Clinical trials have been the gold standard for the evaluation and development of medical interventions for over 70 years [47].”
BackgroundZhao, Y., Huang, Q., Zeng, H., Peng, Y. F., & Sun, H. (2024) · Data Mining and Knowledge Discovery · doi:10.1007/s10618-024-01058-3 · Cited by 8
“However RCTs are time-consuming and expensive, even involving ethical issues in some scenarios (D’Aunno 2010; Malina et al. 2016; Kohavi and Longbotham 2011).”
Foreskin and the molecular politics of risk
Norton, A. T. (2017) · Social Studies of Science · doi:10.1177/0306312717707360 · Cited by 10
“Further, as Bothwell et al. (2016) note, while some robust RCTs’ results get ignored, other results considered robust have in fact turned out to lack external validity, thereby contributing to uncertainty, despite the RCT’s increasing influence over clinical and policy decisions.”
ResultReproducibility in Biomedical Research
Mullane, K., Curtis, M. J., & Williams, M. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804725-5.00001-x · Cited by 11
The Quality of Randomized Controlled Trials in High-impact Rheumatology Journals, 1998–2018
Putman, M., Ragle, A. H., & Ruderman, E. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.191306 · Cited by 9
“Randomized controlled trials (RCT) are the “gold standard” for assessing the efficacy of pharmaceutical interventions.(1) Randomization and blinding help mitigate issues of bias and confounding, which limit the validity of observational data.”
BackgroundShifting Institutional Roles in Biomedical Innovation in a Learning Healthcare System
Eisenberg, R. S. (2017) · Journal of Institutional Economics · doi:10.1017/s1744137418000115 · Cited by 10
Hawthorne Effect: More Than Just Telephones
Nossaman, L. E., & Nossaman, B. D. (2022) · Ochsner Journal · doi:10.31486/toj.22.5031 · Cited by 9
Metadata
- Authors
- Bothwell, L. E., Greene, J. A., Podolsky, S. H., & Jones, D. S.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-06-02
- Volume
- 374
- Issue
- 22
- Pages
- 2175-2181
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2413861456
- Cited by
- 664
- References
- 54
- Citations by year
- 2026: 40 · 2025: 101 · 2024: 59 · 2023: 53 · 2022: 49 · 2021: 76 · 2020: 93 · 2019: 71 · 2018: 74 · 2017: 43 · 2016: 5
- FWCI
- 337.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Arts and Humanities › History and Philosophy of Science › History of Science and Medicine
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Social Sciences › Arts and Humanities › History and Philosophy of Science › Philosophy of Biology and Scientific Explanation
- Keywords
- randomized controlled trials, history of medicine, evidence-based medicine, scientific knowledge production, medical politics, health research funding
- MeSH terms
- Drug Industry, Female, Humans, Legislation, Drug, Pregnancy, Randomized Controlled Trials as Topic, Drug Approval, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.